Medpace is rated Sell, with a $484.49 fair value versus a $612.05 close—implying a 26.33% premium. Click to read more about ...

The Mid Cap Value Fund fell 4.77% in the third quarter, trailing the Russell Midcap® Value Index, which was down 1.98%.

For many Ugandan entrepreneurs, the challenge is no longer finding capital, it is proving that their businesses are ready for ...

OPRO (228A) is a company that sells "SOASU," a system for managing subscription contracts and billing, as well as tools for ...